Drug companies accused of blocking access to cheap drugs

Access to cheap drugs which can prevent blindness is being blocked by pharmaceutical companies, a British Medical Journal investigation has alleged. The Daily Telegraph reports that BMJ describes how drug manufacturers are accused of attempting to derail trials which would show that a drug which costs just £65 a dose works just as well as current treatments sold to the NHS for more than ten times as much.